ACURA PHARMACEUTICALS, INC (13) | Intellectual Property (2)
- Amended License, Development and Commercialization Agreement is made and entered into as of October 16, 2020 by the Registrant and between Abuse Deterrent Pharmaceuticals, LLC (Filed With SEC on March 31, 2021)
- License, Development and Commercialization Agreement is made and entered into as of June 28, 2019 by the Registrant and between Abuse Deterrent Pharmaceuticals, LLC (Filed With SEC on March 31, 2020)